Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

There has been growing interest in developing novel cannabinoid CB1 receptor inverse agonists to treat obesity and its ...

A study on mice found that adding omega-3 polyunsaturated fatty acids to their diets effectively counteracts depressive and ...

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

Medical experts at Shanghai Ruijin Hospital have identified a brain-to-gut signal that controls fat absorption in the ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

A mechanism for metabolic disease is traced to a defective cellular scaffolding that holds together the brain’s hunger cells.

A study has shown a potential new way to treat obesity away from weight loss drugs such as Ozempic. Removing a single gene ...

A study has identified the key role of lateral septum neurons in the effects of the anti-obesity drug liraglutide, offering ...

Today's health news includes concerns that childhood obesity guidelines could increase risk of eating disorders, bird flu ...

Incretin therapies based on GLP-1 receptor agonism aid in the loss of weight in obesity, but a relevant part of this loss (25%-40%) is attributed to loss of lean muscle mass, which raises the risk of ...

Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows ...